Institutional investors hold a majority ownership of AMGN through the 81.67% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ADAMCAPITAL GESTÃO DE RECURSOS L... Bought 236.7 Thousand shares of Amgen Inc
CHURCHILL MANAGEMENT CORP. Bought 102.9 Thousand shares of Amgen Inc